Biologic Drugs With Established Pharmaceutical Class: Human Immunodeficiency Virus 1 Post-attachment Fusion Inhibitor
✉ Email this page to a colleague
Biologic Drugs With Established Pharmaceutical Class: Human Immunodeficiency Virus 1 Post-attachment Fusion Inhibitor
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Theratechnologies Inc. | TROGARZO | ibalizumab-uiyk | Injection | 761065 | 2018-03-06 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |